JAIDS - Journal of Acquired Immune Deficiency Syndromes, is a leading peer-reviewed journal published by Lippincott Williams & Wilkins, focusing on the dynamics of HIV/AIDS and its broader implications in the fields of infectious diseases and pharmacology. With an esteemed impact factor that places it in the prestigious Q1 category for both Infectious Diseases and Pharmacology (medical) as of 2023, this journal aims to provide a platform for groundbreaking research, clinical findings, and innovative therapies relevant to the management and prevention of HIV/AIDS. The journal's rigorous editorial standards and commitment to advancing knowledge make it an essential resource for researchers, healthcare professionals, and students invested in the global response to AIDS. Although the journal does not currently offer open access options, it remains instrumental in disseminating high-quality research that shapes clinical practices and policy developments in the field.

The Canadian Journal of Public Health - Revue Canadienne de Santé Publique, published by Springer International Publishing AG, stands as a pivotal platform for scholarly discourse in the fields of public health and environmental health. With its esteemed position in the Q1 category for both Medicine (miscellaneous) and Public Health, the journal boasts an impressive Scopus ranking that places it within the 80th percentile, reflecting its contribution to advancing knowledge and best practices in public health since its inception in 1945. Situated in Switzerland, this journal serves a global audience of researchers, professionals, and students dedicated to improving public health outcomes. Although it offers traditional access options, its rigorous peer-review process ensures that high-quality research remains at the forefront of its publications. Whether addressing emerging health issues or environmental challenges, the journal plays a vital role in shaping the conversation and policies that influence health systems worldwide.

The Lancet HIV, published by Elsevier Inc in the United Kingdom, stands at the forefront of HIV research and public health, providing a vital platform for the dissemination of innovative findings and critical knowledge in the fields of epidemiology, immunology, infectious diseases, and virology. With its prestigious Q1 rankings in the aforementioned categories for 2023, the journal is recognized for its significant contribution to advancing understanding and addressing challenges posed by HIV globally. Its impressive standing, including a Scopus ranking in the 94th percentile for multiple categories, underscores its impact within the research community. The Lancet HIV publishes rigorously peer-reviewed research articles, reviews, and opinion pieces, ensuring that all stakeholders—researchers, practitioners, and policymakers—are engaged with up-to-date, evidence-based perspectives. Researchers and students alike will find this journal an invaluable resource for enhancing their knowledge and contributing to the ongoing discourse surrounding HIV treatment and prevention.

Global Health & Medicine is a leading journal published by the National Center for Global Health and Medicine (NCGM), dedicated to advancing the fields of public health, epidemiology, and medical research. With the increasing importance of global health issues, this journal serves as a vital resource for researchers, healthcare professionals, and students alike, providing a platform for the dissemination of groundbreaking studies and innovative solutions to health challenges worldwide. Although specific metrics such as HIndex and category quartiles are yet to be established, the journal's commitment to open access ensures that vital information is accessible to a global audience, promoting knowledge sharing across borders. The journal's ISSN and E-ISSN number, 2434-9186 and 2434-9194 respectively, represent its dedication to maintaining high standards in academic publishing. As global health continues to evolve, Global Health & Medicine stands at the forefront, addressing the complexities of health systems, disease prevention, and health promotion essential for fostering a healthier world.

African Health Sciences is a pioneering open access journal published by Makerere University, College of Health Sciences, School of Medicine, devoted to fostering the growth of health science research across the African continent. Established in 2001, this journal serves as a vital platform for disseminating groundbreaking studies and advancements in general medicine, ranked #220 out of 636 in the Scopus category of General Medicine, placing it in the 65th percentile, demonstrating its significance in the field. With a Q3 ranking in the Medicine (miscellaneous) category as of 2023, African Health Sciences not only embraces a diverse scope of topics but also plays an essential role in addressing pressing health challenges faced by African populations. Its open access model ensures that critical health information is freely available to researchers, practitioners, and students, promoting collaboration and knowledge-sharing across the region. As we extend our reach through publications until 2024, African Health Sciences continues to represent an invaluable resource for those committed to enhancing healthcare outcomes in Africa.

LANCET INFECTIOUS DISEASES is a premier journal published by Elsevier Science Ltd, dedicated to disseminating high-quality research and comprehensive reviews in the field of infectious diseases. Since its inception in 2001, the journal has become a pivotal resource in the medical community, recognized for its rigorous peer-review process and impactful contributions to public health. With an impressive Scopus rank of #2 out of 344 in the category of Medicine - Infectious Diseases, it consistently ranks in the 99th percentile, highlighting its importance and influence in shaping clinical and epidemiological research. The journal's commitment to advancing knowledge in infectious diseases is underscored by its Q1 quartile designation in 2023, affirming its status as a leading academic outlet. Although not an open-access journal, LANCET INFECTIOUS DISEASES provides essential insights for researchers, healthcare professionals, and students, bridging the gap between cutting-edge research and practical application in an increasingly interconnected world.

Current HIV/AIDS Reports, published by Springer, is a distinguished scholarly journal that addresses critical developments in the field of HIV/AIDS research. As a leading publication within the Q1 quartiles for both Infectious Diseases and Virology, it serves as an essential platform for researchers and healthcare providers aiming to advance knowledge and practices related to HIV prevention, treatment, and care. With a commitment to publishing innovative studies, reviews, and clinical guidelines, this journal fosters a comprehensive understanding of the complexities surrounding HIV/AIDS. The journal enjoys a robust reputation, evidenced by its impressive Scopus rankings, including a rank of #69 in Infectious Diseases and #21 in Virology, placing it in the top echelons of its field. With an open-access model, *Current HIV/AIDS Reports* significantly enhances the accessibility of crucial research findings to a global audience, driving progress in HIV/AIDS knowledge and public health.

Journal of HIV-AIDS & Social Services is a pivotal academic platform committed to advancing the understanding and management of HIV-AIDS through the lens of social services. Published by Routledge Journals, Taylor & Francis Ltd, this journal spans significant years from 2002 to 2024, making it a key resource for the latest research and practices in the intersecting fields of health and social sciences. With an ISSN of 1538-1501 and an E-ISSN of 1538-151X, the journal holds a respectable position within the academic community, marked by its categorization in the Q3 quartile of both Health (Social Science) and Infectious Diseases as of 2023. The journal strives to provide a forum for innovative research addressing the complexities of HIV-AIDS, incorporating perspectives from various stakeholders, including healthcare providers, policymakers, and community organizations. Although it currently does not offer open access options, its indexed presence and dedicated readership ensure the dissemination of vital knowledge in a field that is more critical than ever. For researchers, professionals, and students dedicated to combating HIV-AIDS, this journal serves not just as a publication, but as a catalyst for change in global health initiatives.

AIDS, published by Lippincott Williams & Wilkins, stands as a premier journal within the fields of immunology and infectious diseases, reflecting a distinguished history since its inception in 1987 and offering insights that shape contemporary research and practice. With an impressive impact factor and categorized in the Q1 quartile across critical areas including Immunology, Infectious Diseases, and Immunology and Allergy, the journal showcases high-quality, peer-reviewed articles that consistently contribute to the advancement of knowledge and innovation in the fight against AIDS and related conditions. Researchers and professionals will find its content invaluable, as it brings forth groundbreaking studies, novel therapeutic approaches, and comprehensive reviews that inform both clinical practices and public health policies. Although not an open access journal, it remains a vital resource for those committed to addressing one of the most pressing global health challenges of our time.

Welcome to AIDS PATIENT CARE AND STDS, a leading journal dedicated to the comprehensive exploration of clinical practices, research advancements, and public health strategies centered around HIV/AIDS and sexually transmitted diseases. Published by Mary Ann Liebert, Inc., this esteemed journal has been at the forefront of disseminating critical findings since 1996, contributing to a robust understanding of the complexities surrounding these global health issues. With an impressive impact factor reflected in its 2023 Q1 quartile rankings in both Infectious Diseases and Public Health, Environmental and Occupational Health, the journal stands out among its peers, ranking at the 95th percentile for Public Health and 91st percentile in Infectious Diseases. Researchers, healthcare professionals, and students will benefit from its rich content, comprehensive studies, and critical reviews that aim to improve care practices and health outcomes. With a clear commitment to fostering knowledge and collaboration in the field, AIDS PATIENT CARE AND STDS is an essential resource for those dedicated to combating these pressing health challenges.